Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ensysce Biosciences ( (ENSC) ) has provided an update.
On March 18, 2026, Ensysce Biosciences Inc. filed a Certificate of Correction with the State of Delaware to amend its Certificate of Designation of Series B Preferred Stock, which forms part of its Certificate of Incorporation. The filing corrects a scrivener’s error in the original designation, representing a technical legal adjustment rather than a change to the company’s core operations or strategic direction.
This administrative correction helps ensure the company’s capital structure documentation accurately reflects its intended terms, supporting clarity for investors and other stakeholders. While the change is limited to fixing drafting language, it underscores the importance of precise corporate filings in maintaining compliance and reducing potential future disputes.
The most recent analyst rating on (ENSC) stock is a Hold with a $0.68 price target. To see the full list of analyst forecasts on Ensysce Biosciences stock, see the ENSC Stock Forecast page.
Spark’s Take on ENSC Stock
According to Spark, TipRanks’ AI Analyst, ENSC is a Neutral.
The score is primarily held down by weak financial performance (shrinking TTM revenue, very negative margins, and ongoing cash burn) and bearish technicals (price below key moving averages with negative MACD). Corporate events provide some offset via added financing and governance/capital-structure actions, but valuation remains hard to justify given ongoing losses and no dividend support.
To see Spark’s full report on ENSC stock, click here.
More about Ensysce Biosciences
Ensysce Biosciences Inc. is a biopharmaceutical company focused on developing and commercializing prescription pharmaceutical products. The company operates within the life sciences sector and concentrates on innovative therapies, positioning itself in a highly regulated and research-driven market.
Average Trading Volume: 6,287,980
Technical Sentiment Signal: Sell
Current Market Cap: $2.12M
See more insights into ENSC stock on TipRanks’ Stock Analysis page.